We are live on ! Find out more
HAE icon

Haemonetics
HAE

242 hedge funds and large institutions have $3.26B invested in Haemonetics in 2022 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 97 increasing their positions, 83 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

97% more call options, than puts

Call options by funds: $3.56M | Put options by funds: $1.81M

23% more capital invested

Capital invested by funds: $2.65B → $3.26B (+$604M)

17% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 83

2.9% more ownership

Funds ownership: 97.99% → 100.9% (+2.9%)

6% less funds holding

Funds holding: 257 → 242 (-15)

33% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 42

Holders
242
Holders Change
-15
Holders Change %
-5.84%
% of All Funds
3.82%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
97
Reduced
83
Closed
42
Calls
$3.56M
Puts
$1.81M
Net Calls
+$1.75M
Net Calls Change
-$10.3M

Top Buyers

1
Capital Research Global Investors
Capital Research Global Investors
California
+$185M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$59.4M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$17.4M
4
EA
Emerald Advisers
Pennsylvania
+$14.5M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$12.1M

Top Sellers

1
AC
Armistice Capital
New York
-$46.3M
2
BlackRock
BlackRock
New York
-$40.3M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$40M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$23.6M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$18.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
101
STRS Ohio
Ohio
$1.49M +$1.19M +21,800 +1,282%
Renaissance Technologies
102
Renaissance Technologies
New York
$1.4M +$1.2M +22,100 New
Jacobs Levy Equity Management
103
Jacobs Levy Equity Management
New Jersey
$1.39M +$1.2M +22,029 New
Millennium Management
104
Millennium Management
New York
$1.32M -$10.2M -187,437 -90%
EP
105
Edgestream Partners
New Jersey
$1.27M -$120K -2,211 -10%
VOYA Investment Management
106
VOYA Investment Management
Georgia
$1.26M +$14.9K +274 +1%
UBS Group
107
UBS Group
Switzerland
$1.26M -$739K -13,583 -41%
SDIC
108
South Dakota Investment Council
South Dakota
$1.23M -$435K -8,000 -29%
COPPSERS
109
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.18M +$97.2K +1,788 +11%
State Board of Administration of Florida Retirement System
110
State Board of Administration of Florida Retirement System
Florida
$1.15M – – –
AIP
111
Ameritas Investment Partners
Nebraska
$1.1M – – –
American Century Companies
112
American Century Companies
Missouri
$1.1M +$587K +10,802 +164%
Ensign Peak Advisors
113
Ensign Peak Advisors
Utah
$1.06M – – –
OPERF
114
Oregon Public Employees Retirement Fund
Oregon
$1.04M -$10K -184 -1%
BCI
115
Brinker Capital Investments
Pennsylvania
$1.02M +$393K +7,233 +81%
ANTB
116
AMG National Trust Bank
Colorado
$1.01M -$15.9K -293 -2%
CCM
117
Cullen Capital Management
New York
$1.01M – – –
WMSA
118
Weiss Multi-Strategy Advisers
New York
$949K -$158K -2,904 -16%
ProShare Advisors
119
ProShare Advisors
Maryland
$920K -$129K -2,369 -14%
AG
120
Algert Global
California
$917K +$36.3K +668 +5%
FAM
121
Fred Alger Management
New York
$882K +$759K +13,956 New
LPL Financial
122
LPL Financial
California
$874K +$146K +2,685 +23%
ASRS
123
Arizona State Retirement System
Arizona
$873K +$4.41K +81 +0.6%
Capstone Investment Advisors
124
Capstone Investment Advisors
New York
$866K – – –
CSS
125
Cubist Systematic Strategies
Connecticut
$858K -$2.66M -48,935 -78%
3 4
5
6 7

HAE Hedge Fund Activity: Q1 2022 in Review

242 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2022, worth a combined $3.26B — up 23% from $2.65B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of HAE and 28 opened new positions — a net loss of 14 holders — while 83 trimmed existing stakes and 97 added.

The largest buyer was Capital Research Global Investors, adding an estimated $185M. The largest seller was Armistice Capital, exiting entirely with an estimated $46.3M sold.

  • 242 institutional investors held Haemonetics (HAE) as of Q1 2022, down from 257 in Q4 2021.
  • Funds reported $3.26B of Haemonetics stock for Q1 2022, up 23% quarter-over-quarter.
  • 28 funds opened new Haemonetics positions in Q1 2022 and 42 closed out, a net change of -14 holders.
  • The largest Haemonetics buyer in Q1 2022 was Capital Research Global Investors, an estimated $185M added.
  • The largest Haemonetics seller in Q1 2022 was Armistice Capital, an estimated $46.3M sold.

Based on aggregated 13F filings for Q1 2022.